Menu
×
West Ashley Library
Closed
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Mobile Library
Closed
Phone: (843) 805-6909
Today's Hours
West Ashley Library
Closed
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Mobile Library
Closed
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
- Author(s): Mendelson M;Mendelson M; Lewnard JA; Lewnard JA; Sharland M; Sharland M; Cook A; Cook A; Cook A; Pouwels KB; Pouwels KB; Alimi Y; Alimi Y; Mpundu M; Mpundu M; Wesangula E; Wesangula E; Weese JS; Weese JS; Røttingen JA; Røttingen JA; Laxminarayan R; Laxminarayan R; Laxminarayan R
- Source:
Lancet (London, England) [Lancet] 2024 Jun 08; Vol. 403 (10443), pp. 2551-2564. Date of Electronic Publication: 2024 May 23.- Publication Type:
Journal Article; Review- Language:
English - Source:
- Additional Information
- Source: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
- Publication Information: Publication: 2004- : London : Elsevier
Original Publication: London : J. Onwhyn - Subject Terms:
- Abstract: Rising antimicrobial resistance (AMR) is a global health crisis for countries of all economic levels, alongside the broader challenge of access to antibiotics. As a result, development goals for child survival, healthy ageing, poverty reduction, and food security are at risk. Preserving antimicrobial effectiveness, a global public good, requires political will, targets, accountability frameworks, and funding. The upcoming second high-level meeting on AMR at the UN General Assembly (UNGA) in September, 2024, is evidence of political interest in addressing the problem of AMR, but action on targets, accountability, and funding, absent from the 2016 UNGA resolution, is needed. We propose ambitious yet achievable global targets for 2030 (relative to a prepandemic 2019 baseline): a 10% reduction in mortality from AMR; a 20% reduction in inappropriate human antibiotic use; and a 30% reduction in inappropriate animal antibiotic use. Given national variation in current levels of antibiotic use, these goals (termed the 10-20-30 by 2030) should be met within a framework of universal access to effective antibiotics. The WHO Access, Watch, Reserve (AWARE) system can be used to define, monitor, and evaluate appropriate levels of antibiotic use and access. Some countries should increase access to narrow-spectrum, safe, and affordable (Access) antibiotics, whereas others should discourage the inappropriate use of broader-spectrum (Watch) and last-resort (Reserve) antibiotics; AWARE targets should use a risk-based, burden-adjusted approach. Improved infection prevention and control, access to clean water and sanitation, and vaccination coverage can offset the selection effects of increased antibiotic use in low-income settings. To ensure accountability and global scientific guidance and consensus, we call for the establishment of the Independent Panel on Antimicrobial Access and Resistance and the support of leaders from low-income and middle-income countries.
Competing Interests: Declaration of interests A meeting held to coordinate this Series paper was supported by the Bill & Melinda Gates Foundation (INV-055356 to RL) and the Africa Centres for Disease Control and Prevention (to all authors). Neither funder had any role in the design, writing, or decision to submit this paper for publication. RL has received grant funding from the National Science Foundation (CCF1918628). WA is an employee of the Africa Centres for Disease Control and Prevention but authored this Series paper in her individual capacity as an expert. JSW has received consulting fees from Mars Veterinary Health, VetMedux, and the Veterinary Information Network; has received payment for lectures from Merck Canada, Vetoquinol, Hills Pet Nutrition, Royal Canin, Zoetis, the Canadian Veterinary Medical Association, and the Ontario Dental Association; and has received payment for expert testimony from the British Columbia Veterinary Medical Association. MS has received academic grant funding from the Global Antibiotic Research and Development Partnership (GARDP) for the design and conduct of clinical studies in the GARDP programme and the European and Developing Countries Clinical Trials Partnership (the NeoSep1 study); had an unpaid leadership position on the WHO Essential Medicine List Antibiotics Working Group; and has been the chief investigator of clinical trials in children, where generic antibiotics have been donated by Sandoz, InfectoPharm, and Shionogi. KBP has received grant funding from the Wellcome Trust, Ineos Oxford Institute for Antimicrobial Resistance Research, Coalition for Epidemic Preparedness and Innovations, UK Health Security Agency, National Institute for Health and Care Research, Medical Research Foundation, Waltham Foundation, and EU-H2020 IMI-2 (jointly funded by IMI-2 and the European Federation of Pharmaceutical Industries and Associations). AC, KBP, and MS also report funding as part of the ADILA Project sponsored by the Wellcome Trust (222051/Z/20/Z). MMe receives funding support from the Wellcome Trust (226690/Z/22/Z). All other authors declare no competing interests.
(Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.) - Accession Number: 0 (Anti-Bacterial Agents)
- Publication Date: Date Created: 20240526 Date Completed: 20240608 Latest Revision: 20240711
- Publication Date: 20240711
- Accession Number: 10.1016/S0140-6736(24)01019-5
- Accession Number: 38797179
- Source:
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.